Welcome!
Covid-19
Tong's Portfolio
Digital value propositions, Telekom and Microsoft
Sectors reporting the most positive surprises include IT, healthcare and financials.
February 05, 2021
Disruption and Digitalisation
Will Covid-19 accelerate productivity growth?
Covid-19 has had a measurable impact on the global economy but gains in productivity from robot use is far trickier to gauge.
February 05, 2021
Investing ideas
Ratcheting past the first gear: transport stocks nudge towards recovery
Transport stocks are starting their engines and driving towards a recovery.
February 05, 2021
Results
Guocoland earnings for 1H21 drop 69% to $22.9 mil on higher tax expense and lower revenue
Revenue for the half-year period stood 44% y-o-y lower at $319.6 million mainly due to lower progressive recognition of sales.
February 04, 2021
Results
SIA plunges into 3Q loss of $142 mil as air travel demand 'severely constrained'
SIA's net loss was primarily driven by the weaker operating performance, though partially offset by a tax credit.
February 04, 2021
Results
SingPost reports slightly lower 3Q20/21 revenue of $351 mil, sees strong growth in e-commerce volumes
Q-o-q, revenue was up by 1% driven by growth in the logistics segment.
February 04, 2021
Covid-19
WEF Special Annual Meeting to be postponed from May to August
"The Singapore Government understands the challenges faced by the World Economic Forum and has agreed to the reschedule."
February 03, 2021
Company in the news
mm2 Asia to tap shareholders for $52.15 mil with 1-for-1 rights issue
Shareholders are entitled to subscribe for a new mm2 Asia rights share at 4.7 cents, a hefty discount of 60.83% to closing price.
February 03, 2021
Results
BRC Asia reports 24% lower 1Q21 earnings of $9.6 mil after provisions of $13.2 mil
1QFY2021 earnings per share (EPS) stood at 4.12 cents on a fully diluted basis.
February 03, 2021
Covid-19
Singapore approves Moderna vaccine, first shipment to arrive in March
Singapore has approved the Moderna Covid-19 vaccine to be used here, making it the second vaccine to be approved.
February 03, 2021